Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus.
- DOI
- 10.1038/s41392-022-01223-4
- Published
- 2022 Oct 17
- Container
- Signal transduction and targeted therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41392-022-01223-4,
title = {Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus.},
author = {Baek YB and Kwon HJ and Sharif M and Lim J and Lee IC and Ryu YB and Lee JI and Kim JS and Lee YS and Kim DH and Park SI and Kim DK and Kim JS and Choy HE and Lee S and Choi HS and Osborne TF and Jeon TI and Cho KO},
year = {2022},
journal = {Signal transduction and targeted therapy},
doi = {10.1038/s41392-022-01223-4},
url = {https://doi.org/10.1038/s41392-022-01223-4}
}RIS
TY - JOUR TI - Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus. AU - Baek YB AU - Kwon HJ AU - Sharif M AU - Lim J AU - Lee IC AU - Ryu YB AU - Lee JI AU - Kim JS AU - Lee YS AU - Kim DH AU - Park SI AU - Kim DK AU - Kim JS AU - Choy HE AU - Lee S AU - Choi HS AU - Osborne TF AU - Jeon TI AU - Cho KO PY - 2022 JO - Signal transduction and targeted therapy DO - 10.1038/s41392-022-01223-4 UR - https://doi.org/10.1038/s41392-022-01223-4 ER -
APA
YB, B., HJ, K., M, S., J, L., IC, L., YB, R., JI, L., JS, K., YS, L., DH, K., SI, P., DK, K., JS, K., HE, C., S, L., HS, C., TF, O., TI, J., & KO, C. (2022). Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-022-01223-4
Source records
- pubmed · retrieved 2026-09-26T12:56:59.779Z